Picture of OWC Pharmaceutical Research logo

OWCP OWC Pharmaceutical Research Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for OWC Pharmaceutical Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2014
December 31st
2015
December 31st
2016
December 31st
2017
December 31st
2018
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-5.07-1.65-2.29-4.56-10.3
Depreciation
Non-Cash Items4.460.3741.673.37.56
Other Non-Cash Items
Changes in Working Capital0.0070.0550.0820.060.19
Change in Accounts Receivable
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Cash from Operating Activities-0.602-1.22-0.529-1.19-2.5
Capital Expenditures-0.032-0.003-0.002-0.01-0.028
Purchase of Fixed Assets
Cash from Investing Activities-0.032-0.003-0.002-0.01-0.028
Financing Cash Flow Items0.02800.0510.105
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.090.1240.6461.695.02
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.47-1.110.1150.4982.49